Trends towards an improved disease state in rheumatoid arthritis over time: Influence of new therapies and changes in management approach: Analysis of the EMECAR cohort

Arthritis Research and Therapy

Volumn 10, Issue 6, 2008, Pages

  González Alvaro, Isidoro ^a   Descalzo, Miguel Angel ^b   Carmona, Loreto ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIDAD DE INVESTIGACIÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; QUESTIONNAIRE; REGISTRATION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE MANAGEMENT; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT; TIME;

ACTIVITIES OF DAILY LIVING; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DISEASE MANAGEMENT; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 57449111232     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2561     Document Type: Article

References (32)

1. Gartlehner G Hansen RA Jonas BL Thieda P Lohr KN The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: A systematic review and metaanalysis J Rheumatol 2006, 33:2398-2408. 17225293
2. Smolen JS Kalden JR Scott DL Rozman B Kvien TK Larsen A Loew-Friedrich I Oed C Rosenburg R Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial. European Leflunomide Study Group Lancet 1999, 353:259-266. 10.1016/S0140-6736(98)09403-3 9929017
3. Sokka T Pincus T Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis Arthritis Rheum 2003, 48:313-318. 10.1002/art.10817 12571838
4. Gonzalez-Alvaro I Carmona L Balsa A Sanmarti R Belmonte MA Tena X Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis J Rheumatol 2003, 30:697-704. 12672186
5. Gonzalez-Alvaro I Hernandez-Garcia C Villaverde Garcia V Vargas E Ortiz AM Variations in the drug treatment of rheumatoid arthritis in Spain Med Clin (Barc) 2002, 118:771-776. 12049692
6. Carmona L Gonzalez-Alvaro I Balsa A Angel Belmonte M Tena X Sanmarti R Rheumatoid arthritis in Spain: Occurrence of extra-articular manifestations and estimates of disease severity Ann Rheum Dis 2003, 62:897-900. 1754657 12922967 10.1136/ard.62.9.897
7. Arnett FC Edworthy SM Bloch DA McShane DJ Fries JF Cooper NS Healey LA Kaplan SR Liang MH Luthra HS Medsger TA Mitchell DM Neustadt DH Pinals RS Schaller JG Sharp JT Wilder RL Hunder GG The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302 3358796
8. Prevoo ML van't Hof MA Kuper HH van Leeuwen MA Putte van de LB van Riel PL Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107 7818570
9. Esteve-Vives J Batlle-Gualda E Reig A Spanish version of the Health Assessment Questionnaire: Reliability, validity and transcultural equivalency. Grupo para la Adaptacion del HAQ a la Poblacion Espanola J Rheumatol 1993, 20:2116-2122. 8014941
10. Scott DL Houssien DA Laasonen L Proposed modification to Larsen's scoring methods for hand and wrist radiographs Br J Rheumatol 1995, 34:56. Brief report. 10.1093/rheumatology/34.1.56 7881840
11. Dufouil C Brayne C Clayton D Analysis of longitudinal studies with death and drop-out: A case study Stat Med 2004, 23:2215-2226. 10.1002/sim.1821 15236426
12. Hardin J Hilbe J Generalized Linear Models and Extensions College Station, TX: Stata Press 2 2007.
13. Pan W Model selection in estimating equations Biometrics 2001, 57:529-534. 10.1111/j.0006-341X.2001.00529.x 11414579
14. Landewe RB Boers M Verhoeven AC Westhovens R Laar van de MA Markusse HM van Denderen JC Westedt ML Peeters AJ Dijkmans BA Jacobs P Boonen A Heijde van der DM Linden van der S COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention Arthritis Rheum 2002, 46:347-356. 10.1002/art.10083 11840436
15. Young A Early rheumatoid arthritis Rheum Dis Clin North Am 2005, 31:659-679. 10.1016/j.rdc.2005.07.011 16287590
16. Gonzalez-Alvaro I Hernandez-Garcia C El estudio emAR. Variabilidad en el uso de recursos terapéuticos emAR Estudio sobre el manejo de la Artritis Reumatoide Barcelona: TINGS Servicios de Comunicación 2001:92-128.
17. Villaverde V Hernandez-Garcia C Gonzalez-Alvaro I Vargas E Abásolo L Morado IC Lajas C grupo Estudio emAR Estudio sobre la variabilidad en el seguimiento de los pacientes con artritis reumatoide en España. Resultados del estudio emAR Rev Esp Reumatol 2002, 30:110-118.
18. Genovese MC Bathon JM Martin RW Fleischmann RM Tesser JR Schiff MH Keystone EC Wasko MC Moreland LW Weaver AL Markenson J Cannon GW Spencer-Green G Finck BK Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two-year radiographic and clinical outcomes Arthritis Rheum 2002, 46:1443-1450. 10.1002/art.10308 12115173
19. Breedveld FC Weisman MH Kavanaugh AF Cohen SB Pavelka K van Vollenhoven R Sharp J Perez JL Spencer-Green GT The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 2006, 54:26-37. 10.1002/art.21519 16385520
20. Guipcar G Guía de Práctica Clínica para el manejo de la Artritis Reumatoide en España 2007. http://www.ser.es/ practicaClinica/Guias_Practica_Clinica.php
21. Godinho F Godfrin B El Mahou S Navaux F Zabraniecki L Cantagrel A Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis Clin Exp Rheumatol 2004, 22:328-330. 15144127
22. Hansen KE Cush J Singhal A Cooley DA Cohen S Patel SR Genovese M Sundaramurthy S Schiff M The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis Arthritis Rheum 2004, 51:228-232. 10.1002/art.20228 15077264
23. Kremer JM Genovese MC Cannon GW Caldwell JR Cush JJ Furst DE Luggen ME Keystone E Weisman MH Bensen WM Kaine JL Ruderman EM Coleman P Curtis DL Kopp EJ Kantor SM Waltuck J Lindsley HB Markenson JA Strand V Crawford B Fernando I Simpson K Bathon JM Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial Ann Intern Med 2002, 137:726-733. 12416946
24. Lipsky PE Heijde van der DM St Clair EW Furst DE Breedveld FC Kalden JR Smolen JS Weisman M Emery P Feldmann M Harriman GR Maini RN A-T NFTiRAwCT Study Group Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group N Engl J Med 2000, 343:1594-1602. 10.1056/NEJM200011303432202 11096166
25. Ortiz Garcia AM Gonzalez-Alvaro I Rosello Pardo R Carmona L Fabregas Canales MD Monteagudo Saez I Effectiveness and safety of infliximab combined with leflunomide in chronic polyarthritis Clin Exp Rheumatol 2004, 22:790. Letter. 15638063
26. Finckh A Choi HK Wolfe F Progression of radiographic joint damage in different eras: Trends towards milder disease in rheumatoid arthritis are attributable to improved treatment Ann Rheum Dis 2006, 65:1192-1197. 10.1136/ard.2005.049338 16540549
27. Gerards AH Landewe RB Prins AP Bruyn GA Goei The HS Laan RF Dijkmans BA Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: A double blind randomised placebo controlled trial Ann Rheum Dis 2003, 62:291-296. 1754491 12634224 10.1136/ard.62.4.291
28. Tugwell P Pincus T Yocum D Stein M Gluck O Kraag G McKendry R Tesser J Baker P Wells G Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group N Engl J Med 1995, 333:137-141. 10.1056/ NEJM199507203330301 7791814
29. Ziolkowska M Koc A Luszczykiewicz G Ksiezopolska-Pietrzak K Klimczak E Chwalinska-Sadowska H Maslinski W High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism J Immunol 2000, 164:2832-2838. 10679127
30. Jones G Halbert J Crotty M Shanahan EM Batterham M Ahern M The effect of treatment on radiological progression in rheumatoid arthritis: A systematic review of randomized placebo-controlled trials Rheumatology (Oxford) 2003, 42:6-13. 10.1093/rheumatology/keg036 12509606
31. Kirwan JR Conceptual issues in scoring radiographic progression in rheumatoid arthritis J Rheumatol 1999, 26:720-725. 10090190
32. Listing J Strangfeld A Rau R Kekow J Gromnica-Ihle E Klopsch T Demary W Burmester GR Zink A Clinical and functional remission: Even though biologics are superior to conventional DMARDs overall success rates remain low-results from RABBIT, the German biologics register Arthritis Res Ther 2006, 8:R66. 1526636 16600016 10.1186/ar1933